Navigation Links
Abbreviated Trials Yield Misleading Results: Study
Date:3/23/2010

Researchers must resist pressure for early halt, expert says

TUESDAY, March 23 (HealthDay News) -- Many positive treatment effects are exaggerated in clinical trials that are stopped early due to encouraging results, a new study has found.

In a comparison of 91 truncated trials with 424 comparable full-length trials, researchers found that the trials that ended early -- in particular, smaller studies -- reported exaggerated or misleading treatment effects.

"Our research shows that in most cases, early stopping of clinical trials resulted in misleading estimates of treatment effects. These misleading estimates are likely to result in misguided decisions about the trade-off between risks and benefits of a therapy," study corresponding author Dr. Victor Montori, a Mayo Clinic endocrinologist, said in a news release.

"On average, treatments with no effect would show a reduction in relative risk of almost 30 percent in stopped early trials. Treatments with a true relative risk reduction of 20 percent would show a reduction of over 40 percent," Montori said.

Almost everyone -- doctors, researchers, funding sources, drug makers, medical journals -- benefits from a clinical trial ending early, Montori noted. But patients don't benefit because they may end up receiving a therapy on the basis of misleading information about its benefits.

Montori and colleagues said that researchers must resist pressure to end clinical trials early and continue trials until they're nearly completed before even considering an early halt.

The study was published March 23 in the Journal of the American Medical Association.

More information

The U.S. National Institutes of Health has more about clinical trials.



-- Robert Preidt



SOURCE: Mayo Clinic, news release, March 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. FDA Issues Guidance to Help Streamline Medical Device Clinical Trials
2. European Cancer Organization supports a revision of the EU Clinical Trials Directive
3. Human guinea pigs wary of high-paying medical trials
4. Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
5. ePRO on Netbooks (NetPRO) - The BEST ePRO Solution for Clinical Trials in 15 Years
6. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
7. Mesothelioma Clinical Trials List Offered by IQ Mesothelioma: Search Current Mesothelioma Treatment Options
8. State payer mandates to cover cancer trials offer heterogeneous protection for patients
9. LSUHSC research yields promising stroke treatment
10. Compulsive Dogs Yield Clues to Human OCD, Autism
11. Battlefield camaraderie yields long-term dividends for veterans, study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... ... May 22, 2017 , ... Faithfully following pop culture, people today are ... toned and shaped through fitness programs. It carries on to skin nourished, pampered and ... an irresistible, radiant smile. CDA has found that just like a perfectly ...
(Date:5/21/2017)... ... May 19, 2017 , ... HealthSmart, the largest independent ... (Jim) Vertino as Chief Information Officer (CIO). He will be joining HealthSmart at ... and business performance. He defines strategic roadmaps by reimagining business processes—bridging the gap ...
(Date:5/21/2017)... Amarillo, Texas (PRWEB) , ... May 21, 2017 ... ... Feminism International Conference has brought together a cross-disciplinary group of scholars, policymakers, and ... Breastfeeding, Social Justice, and Equity is the third book from a ...
(Date:5/21/2017)... ... May 21, 2017 , ... ... been longer than six months since you've seen a dentist, it's time for ... year and getting x-rays once per year. , Dental checkups are a relatively ...
(Date:5/19/2017)... ... May 19, 2017 , ... When Kyle Busch graduates from ... will already appear on two major research studies that could impact the health of ... Matt Daggett, KCU alumnus and an orthopedic surgeon, alongside an international team trying to ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)...  Bayer announced today that the latest research from ... the 53 rd Annual Meeting of the American ... in Chicago . ... liver and thyroid cancers, as well as lymphomas, and ... trial of copanlisib in patients with relapsed or refractory ...
(Date:5/10/2017)... May 10, 2017 Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended April 1, 2017 ... $1.84 increased 666.7% compared to the prior year period ... in a significant gain, while non-GAAP diluted EPS of ... or 3.8% in constant currency terms.  Excluding the effects ...
(Date:5/9/2017)... , May 9, 2017 Zimmer Biomet ... in musculoskeletal healthcare, today announced it has earned a ... of 2017" list. The Company was ranked among 500 ... Large Employers and Healthcare Equipment and Services. ... based on an anonymous, independent survey of over 30,000 ...
Breaking Medicine Technology: